Aprea Therapeutics, Inc.

Q4 2024 13F Holders

Symbol
APRE
CUSIP
03836J201
Type
Equity
Class
COM NEW
Num filings
27
Total reported value, excl. options
$6.83 M
Manager Report Date Value ($000) Shares Option Type